← FDA Drug Approvals (Drugs@FDA)

BENZONATATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MARKSANS PHARMA · Approved 2026-03-30

Drug application

FDA Application #

ANDA220298

Application type

Abbreviated New Drug Application (Generic)

Brand name

BENZONATATE

Generic name

BENZONATATE 100 MG

Active ingredients

BENZONATATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

MARKSANS PHARMA

Manufacturer

MARKSANS PHARMA LIMITED

First approval

2026-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown